Unknown

Dataset Information

Multimodal Neuroimaging in Rett Syndrome With MECP2 Mutation.


ABSTRACT: Rett syndrome (RTT) is a rare neurodevelopmental disorder characterized by severe cognitive, social, and physical impairments resulting from de novo mutations in the X-chromosomal methyl-CpG binding protein gene 2 (MECP2). While there is still no cure for RTT, exploring up-to date neurofunctional diagnostic markers, discovering new potential therapeutic targets, and searching for novel drug efficacy evaluation indicators are fundamental. Multiple neuroimaging studies on brain structure and function have been carried out in RTT-linked gene mutation carriers to unravel disease-specific imaging features and explore genotype-phenotype associations. Here, we reviewed the neuroimaging literature on this disorder. MRI morphologic studies have shown global atrophy of gray matter (GM)

SUBMITTER: Kong Y 

PROVIDER: S-EPMC8904872 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature